Prognostic significance of lactate/proton symporters MCT1, MCT4, and their chaperone CD147 expressions in urothelial carcinoma of the bladder.

[1]  J. Cleveland,et al.  Targeting lactate metabolism for cancer therapeutics. , 2013, The Journal of clinical investigation.

[2]  O. Féron,et al.  Endothelial cell metabolism and tumour angiogenesis: glucose and glutamine as essential fuels and lactate as the driving force , 2013, Journal of internal medicine.

[3]  Jorma Isola,et al.  ImmunoMembrane: a publicly available web application for digital image analysis of HER2 immunohistochemistry , 2012, Histopathology.

[4]  A. Halestrap,et al.  The monocarboxylate transporter family—Role and regulation , 2012, IUBMB life.

[5]  B. Toole,et al.  Regulation of invadopodia formation and activity by CD147 , 2012, Journal of Cell Science.

[6]  Zhiyan Sun,et al.  CD147 overexpression is a prognostic factor and a potential therapeutic target in bladder cancer , 2011, Medical oncology.

[7]  R. Reis,et al.  Monocarboxylate transporter 4 (MCT4) and CD147 overexpression is associated with poor prognosis in prostate cancer , 2011, BMC Cancer.

[8]  M. Slomiany,et al.  Cooperative roles for emmprin and LYVE-1 in the regulation of chemoresistance for primary effusion lymphoma , 2011, Leukemia.

[9]  W. Zhong,et al.  Extracellular matrix metalloproteinase inducer expression has an impact on survival in human bladder cancer. , 2010, Cancer epidemiology.

[10]  Yong Li,et al.  Co-expression of CD147/EMMPRIN with monocarboxylate transporters and multiple drug resistance proteins is associated with epithelial ovarian cancer progression , 2010, Clinical & Experimental Metastasis.

[11]  A. Longatto-Filho,et al.  Expression of Monocarboxylate Transporters 1, 2, and 4 in Human Tumours and Their Association with CD147 and CD44 , 2010, Journal of biomedicine & biotechnology.

[12]  B. Zilberstein,et al.  The prognostic value of CD147/EMMPRIN is associated with monocarboxylate transporter 1 co-expression in gastric cancer. , 2009, European journal of cancer.

[13]  Julien Verrax,et al.  Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. , 2008, The Journal of clinical investigation.

[14]  M. Inoue,et al.  Blocking CD147 induces cell death in cancer cells through impairment of glycolytic energy metabolism. , 2008, Biochemical and biophysical research communications.

[15]  N. Philp,et al.  Monocarboxylate transporter 4 regulates maturation and trafficking of CD147 to the plasma membrane in the metastatic breast cancer cell line MDA-MB-231. , 2007, Cancer research.

[16]  D. Bok,et al.  Mechanisms regulating tissue-specific polarity of monocarboxylate transporters and their chaperone CD147 in kidney and retinal epithelia. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[17]  M. Hemler,et al.  Metabolic Activation-related CD147-CD98 Complex*S , 2005, Molecular & Cellular Proteomics.

[18]  Yi Tang,et al.  Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases. , 2005, Cancer research.

[19]  R. Gillies,et al.  Why do cancers have high aerobic glycolysis? , 2004, Nature Reviews Cancer.

[20]  M. Crundwell.  Pathology and genetics of tumours of the urinary system and male genital organs , 2004 .

[21]  Wei Tang,et al.  Caveolin-1 Regulates Matrix Metalloproteinases-1 Induction and CD147/EMMPRIN Cell Surface Clustering* , 2004, Journal of Biological Chemistry.

[22]  D. Meredith,et al.  The SLC16 gene family—from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond , 2004, Pflügers Archiv.

[23]  H. Uramoto,et al.  Cellular pH regulators: potentially promising molecular targets for cancer chemotherapy. , 2003, Cancer treatment reviews.

[24]  B. Toole,et al.  Tumorigenic potential of extracellular matrix metalloproteinase inducer. , 2001, The American journal of pathology.

[25]  A. Lardner.  The effects of extracellular pH on immune function , 2001, Journal of leukocyte biology.

[26]  S. Bröer,et al.  The low-affinity monocarboxylate transporter MCT4 is adapted to the export of lactate in highly glycolytic cells. , 2000, The Biochemical journal.

[27]  A. Barclay,et al.  CD147 is tightly associated with lactate transporters MCT1 and MCT4 and facilitates their cell surface expression , 2000, The EMBO journal.

[28]  K. Nabeshima,et al.  Monoclonal antibody preparation and purification of a tumor cell collagenase-stimulatory factor. , 1989, Cancer research.

[29]  M. Polette,et al.  EMMPRIN-mediated MMP regulation in tumor and endothelial cells , 2004, Clinical & Experimental Metastasis.

[30]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.